Free Trial

Scinai Immunotherapeutics (SCNI) Competitors

Scinai Immunotherapeutics logo
$3.31 -0.03 (-0.90%)
Closing price 02/18/2025 03:59 PM Eastern
Extended Trading
$3.31 0.00 (-0.03%)
As of 02/18/2025 06:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SCNI vs. DWTX, TXMD, BCDA, PMCB, KPRX, TLPH, BCTX, PHXM, AEON, and CYCN

Should you be buying Scinai Immunotherapeutics stock or one of its competitors? The main competitors of Scinai Immunotherapeutics include Dogwood Therapeutics (DWTX), TherapeuticsMD (TXMD), BioCardia (BCDA), PharmaCyte Biotech (PMCB), Kiora Pharmaceuticals (KPRX), Talphera (TLPH), BriaCell Therapeutics (BCTX), PHAXIAM Therapeutics (PHXM), AEON Biopharma (AEON), and Cyclerion Therapeutics (CYCN). These companies are all part of the "pharmaceutical products" industry.

Scinai Immunotherapeutics vs.

Dogwood Therapeutics (NASDAQ:DWTX) and Scinai Immunotherapeutics (NASDAQ:SCNI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk.

Dogwood Therapeutics is trading at a lower price-to-earnings ratio than Scinai Immunotherapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dogwood TherapeuticsN/AN/A-$5.30M-$6.55-0.91
Scinai ImmunotherapeuticsN/AN/A-$6.50M-$239.17-0.01

Dogwood Therapeutics has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Scinai Immunotherapeutics has a beta of 2.37, meaning that its share price is 137% more volatile than the S&P 500.

In the previous week, Scinai Immunotherapeutics had 1 more articles in the media than Dogwood Therapeutics. MarketBeat recorded 1 mentions for Scinai Immunotherapeutics and 0 mentions for Dogwood Therapeutics. Scinai Immunotherapeutics' average media sentiment score of 1.00 beat Dogwood Therapeutics' score of 0.00 indicating that Scinai Immunotherapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Dogwood Therapeutics Neutral
Scinai Immunotherapeutics Positive

Scinai Immunotherapeutics' return on equity of 0.00% beat Dogwood Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dogwood TherapeuticsN/A -217.12% -172.06%
Scinai Immunotherapeutics N/A N/A -30.48%

Dogwood Therapeutics and Scinai Immunotherapeutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Dogwood TherapeuticsN/AN/A
Scinai ImmunotherapeuticsN/AN/A

9.1% of Dogwood Therapeutics shares are held by institutional investors. Comparatively, 58.4% of Scinai Immunotherapeutics shares are held by institutional investors. 12.2% of Dogwood Therapeutics shares are held by insiders. Comparatively, 60.9% of Scinai Immunotherapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Scinai Immunotherapeutics beats Dogwood Therapeutics on 8 of the 10 factors compared between the two stocks.

Get Scinai Immunotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCNI vs. The Competition

MetricScinai ImmunotherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$2.81M$3.10B$5.77B$9.20B
Dividend YieldN/A1.67%5.29%3.98%
P/E Ratio-0.0147.2326.4419.51
Price / SalesN/A333.31449.4569.98
Price / CashN/A192.7646.0638.90
Price / Book-0.344.057.255.07
Net Income-$6.50M-$40.60M$3.19B$222.54M
7 Day Performance-0.30%3.18%1.41%2.13%
1 Month Performance-5.70%3.69%3.50%1.63%
1 Year Performance-31.08%-12.15%20.82%16.41%

Scinai Immunotherapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCNI
Scinai Immunotherapeutics
1.4332 of 5 stars
$3.31
-0.9%
N/A-31.1%$2.81MN/A-0.0120Positive News
Gap Up
DWTX
Dogwood Therapeutics
N/A$8.77
-18.3%
N/AN/A$11.68MN/A-1.345Gap Down
TXMD
TherapeuticsMD
1.1985 of 5 stars
$1.01
-1.0%
N/A-54.9%$11.65M$1.60M0.00420Gap Down
BCDA
BioCardia
3.2085 of 5 stars
$2.37
flat
$25.00
+954.9%
-59.5%$10.86M$480,000.00-0.5740Gap Down
PMCB
PharmaCyte Biotech
0.7371 of 5 stars
$1.55
+4.0%
N/A-23.7%$10.80MN/A2.924Negative News
Gap Down
KPRX
Kiora Pharmaceuticals
2.6663 of 5 stars
$3.60
flat
$10.00
+177.8%
-35.2%$10.80MN/A0.0010Short Interest ↑
TLPH
Talphera
2.6811 of 5 stars
$0.63
-3.1%
$4.33
+587.9%
-50.1%$10.73M$650,000.00-0.9119
BCTX
BriaCell Therapeutics
3.3617 of 5 stars
$3.62
-2.9%
$32.00
+784.0%
-89.6%$10.68MN/A-0.278Positive News
Gap Up
PHXM
PHAXIAM Therapeutics
N/A$3.10
flat
N/AN/A$10.58M$32.66M0.0049
AEON
AEON Biopharma
2.3199 of 5 stars
$0.13
-0.3%
$5.00
+3,749.1%
-98.9%$10.39MN/A0.725Gap Down
CYCN
Cyclerion Therapeutics
0.9726 of 5 stars
$3.82
-9.3%
N/A+7.3%$10.35M$1.62M0.0030Negative News

Related Companies and Tools


This page (NASDAQ:SCNI) was last updated on 2/19/2025 by MarketBeat.com Staff
From Our Partners